<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="prop1" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">prop1</book-part-id>
      <title-group>
        <title>
<italic toggle="yes">PROP1</italic>-Related Combined Pituitary Hormone Deficiency</title>
        <alt-title alt-title-type="alt-title">Synonym: <italic toggle="yes">PROP1</italic>-Related CPHD</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>de Graaff</surname>
            <given-names>Laura CG</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <email>l.degraaff@erasmusmc.nl</email>
          <aff>Erasmus Medical Center<break/>Rotterdam, The Netherlands</aff>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2000-12-07" date-type="created">
          <day>7</day>
          <month>12</month>
          <year>2000</year>
        </date>
        <date iso-8601-date="2014-08-07" date-type="updated">
          <day>7</day>
          <month>8</month>
          <year>2014</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="me-ataxia" document-type="chapter">
<italic toggle="yes">PRICKLE1</italic>-Related Progressive Myoclonus Epilepsy with Ataxia</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="prss1-hp" document-type="chapter">
<italic toggle="yes">PRSS1</italic>-Related Hereditary Pancreatitis</related-object>
      <abstract id="prop1.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p><italic toggle="yes">PROP1</italic>-related combined pituitary hormone deficiency (CPHD) is associated with deficiencies of growth hormone (GH); thyroid-stimulating hormone (TSH); the two gonadotropins, luteinizing hormone (LH) and follicle-stimulating hormone (FSH); prolactin (PrL); and occasionally adrenocorticotropic hormone (ACTH). Most affected individuals are ascertained because of growth failure and failure to thrive starting in infancy or early childhood (approximate age range: 9 months to 8 years). Hypothyroidism is usually mild and occurs in later infancy and childhood. Affected individuals can have absent or delayed and incomplete secondary sexual development with infertility. Untreated males usually have a small penis and small testes. Some females experience menarche, but subsequently require hormone replacement therapy. ACTH deficiency is less common and, when present, usually occurs in adolescence or adulthood.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>Testing for deficient secretion of GH, TSH, LH, FSH, PrL, and ACTH establishes the diagnosis of CPHD. <italic toggle="yes">PROP1</italic> is the only gene in which pathogenic variants are known to cause <italic toggle="yes">PROP1</italic>-related CPHD.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> GH deficiency is treated with injection of biosynthetic growth hormone from the time of diagnosis until approximately age 17 years. TSH deficiency is treated by thyroid hormone replacement in the form of oral L-thyroxine. In infants with LH and FSAH deficiency micropenis is treated with a limited course of testosterone. Hormone replacement to induce secondary sex characteristics can be initiated in males at age 12 to 13 years with monthly injections of testosterone enanthate and in females at age 11 to 12 years with conjugated estrogens or ethinyl estradiol and later by cycling with estrogen and progesterone. Fertility in both sexes is possible with administration of gonadotropins. ACTH deficiency is treated with oral hydrocortisone.</p>
          <p><italic toggle="yes">Surveillance:</italic> Regular follow up for all affected individuals to monitor for effectiveness and/or complications of hormone replacement therapy and for evidence of other hormone deficiencies.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> For younger sibs: if both (paternal and maternal) <italic toggle="yes">PROP1</italic> pathogenic variants are known perform molecular genetic testing to enable early diagnosis and treatment, otherwise monitor growth for evidence of growth failure.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p><italic toggle="yes">PROP1</italic>-related CPHD is inherited in an autosomal recessive manner. At conception, the sibs of an affected individual have a 25% chance of being affected, a 50% chance of being asymptomatic carriers, and a 25% chance of being unaffected and not carriers. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible when both paternal and maternal <italic toggle="yes">PROP1</italic> pathogenic variants are known.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="prop1.Diagnosis">
        <title>Diagnosis</title>
        <sec id="prop1.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>The diagnosis of combined pituitary hormone deficiency (CPHD) requires the presence of growth hormone (GH) deficiency and deficiency of at least one of the following other pituitary hormones:</p>
          <list list-type="bullet">
            <list-item>
              <p>Thyroid-stimulating hormone (TSH)</p>
            </list-item>
            <list-item>
              <p>The two gonadotropins, luteinizing hormone (LH) and follicle-stimulating hormone (FSH)</p>
            </list-item>
            <list-item>
              <p>Prolactin (PrL)</p>
            </list-item>
            <list-item>
              <p>Less frequently, adrenocorticotropic hormone (ACTH)</p>
            </list-item>
          </list>
          <p>The diagnosis of <italic toggle="yes">PROP1</italic>-related combined pituitary hormone deficiency, the focus of this <italic toggle="yes">GeneReview</italic>, requires the diagnosis of CPHD and identification of at least one <italic toggle="yes">PROP1</italic> pathogenic variant.</p>
          <p><bold>Growth hormone (GH) deficiency</bold> is suspected in children with:</p>
          <list list-type="bullet">
            <list-item>
              <p>Neonatal hypoglycemia AND/OR</p>
            </list-item>
            <list-item>
              <p>Proportionate short stature and delayed bone maturation (in the absence of an inherited bone dysplasia or chronic disease) with the following growth patterns [<xref ref-type="bibr" rid="prop1.REF.rosenfeld.1996">Rosenfeld 1996</xref>]:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Severe short stature with height more than three standard deviations (SD) below the mean for age OR</p>
                </list-item>
                <list-item>
                  <p>Moderate short stature with height 2-3 SD below the mean for age and growth deceleration with height velocity less than 25th percentile for age OR</p>
                </list-item>
                <list-item>
                  <p>Severe growth deceleration with height velocity less than fifth percentile for age</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p><bold>Thyroid-stimulating hormone (TSH) deficiency</bold> is suspected in the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Infants over age one month with large posterior fontanelle (diameter &#x0003e;1 cm), jaundice that lasts for more than one week after birth, macroglossia, hoarse cry, distended abdomen, umbilical hernia, excessive sleeping, and hypotonia Note: Infants with congenital hypothyroidism may show no signs in the first month of life.</p>
            </list-item>
            <list-item>
              <p>Children with growth failure, poor weight gain, and delayed bone maturation</p>
            </list-item>
          </list>
          <p><bold>Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) deficiency</bold> is suspected in the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Newborn males with micropenis (stretched penile length &#x0003c;2.5 cm in a term infant) without hypospadias, with or without cryptorchidism</p>
            </list-item>
            <list-item>
              <p>Adolescent males with onset of puberty after age 14 years or cessation of secondary sexual development</p>
            </list-item>
            <list-item>
              <p>Adolescent females with lack of breast development or menses by age 14 years</p>
            </list-item>
          </list>
          <p><bold>Prolactin (PrL) deficiency</bold> is suspected in females with impaired lactation.</p>
          <p><bold>Adrenocorticotropic hormone (ACTH) deficiency</bold> is suspected in children and adults with persistent weakness, fever, abdominal pain, anorexia, and weight loss. Signs of acute ACTH deficiency include acute hypotension, dehydration, and shock accompanied by hyponatremia, hyperkalemia, and hypoglycemia.</p>
        </sec>
        <sec id="prop1.Testing">
          <title>Testing</title>
          <p>Testing concomitantly for deficient secretion of GH, TSH, LH, FSH, PrL, and ACTH should be performed for diagnosis and management [<xref ref-type="bibr" rid="prop1.REF.phillips.1995">Phillips 1995</xref>, <xref ref-type="bibr" rid="prop1.REF.rimoin.1997">Rimoin &#x00026; Phillips 1997</xref>].</p>
          <p>Deficiencies of all pituitary hormones may be assessed simultaneously using a triple test comprising the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Insulin-induced hypoglycemia (with a blood sugar &#x0003c;40 mg/dL or half the baseline value), which should increase the serum concentration of growth hormone, prolactin, and cortisol</p>
            </list-item>
            <list-item>
              <p>TRH (thyrotropin-releasing hormone), which should increase serum concentrations of TSH and PrL</p>
            </list-item>
            <list-item>
              <p>Exogenous GnRH (gonadotropin-releasing hormone), which should increase serum concentrations of LH and FSH</p>
            </list-item>
          </list>
          <p><bold>Growth hormone (GH) deficiency.</bold> Note: (1) Even in the appropriate clinical setting, the diagnosis of GH deficiency remains problematic because of the difficulty in measuring physiologic GH secretion. (2) Provocative tests of GH secretion are widely used in the diagnosis of GH deficiency, although they are associated with a high false positive rate.</p>
          <p>Stimuli used for provocative testing for GH deficiency include exercise, arginine, L-dopa, clonidine, insulin, insulin-arginine, glucagon, and propranolol.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Confirmatory finding.</bold> Serum concentration of GH less than 7-10 ng/dL on two provocative testsNote: A peak serum concentration of GH greater than 7-10 ng/mL on one test rules out the diagnosis of GH deficiency.</p>
            </list-item>
          </list>
          <p>
            <bold>Thyroid-stimulating hormone (TSH) deficiency</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Suggestive finding.</bold> Serum T<sub>4</sub> concentration 1.0 &#x000b5;g/dL below normal for age with a low serum TSH concentration (normal: 0.1 mU/L to 4.5-5.5 mU/L)</p>
            </list-item>
            <list-item>
              <p><bold>Confirmatory finding.</bold> Subnormal increase in serum concentration of TSH 30 minutes after infusion of TRH</p>
            </list-item>
          </list>
          <p>Note: All newborn screening programs for congenital hypothyroidism screen for elevated TSH. Persons with central hypothyroidism normally have low thyroid hormone concentrations associated with inappropriately low/normal TSH levels. Note: In countries in which the neonatal screening program is based on TSH levels only, such individuals are not detected.</p>
          <p>
            <bold>Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) deficiency</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Suggestive finding.</bold> Low serum concentrations of LH and FSH and low serum testosterone concentration in males; low serum estradiol concentration (and/or the lack of progestin-induced withdrawal bleeding) in females age 14 years or older</p>
            </list-item>
            <list-item>
              <p><bold>Confirmatory finding.</bold> Subnormal increase in serum concentration of LH and FSH following infusion of GnRH in an individual age 14 years or older Note: No absolute cutoff values have been established.</p>
            </list-item>
          </list>
          <p>
            <bold>Prolactin (PrL) deficiency</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Suggestive finding.</bold> Very low or undetectable baseline prolactin</p>
            </list-item>
            <list-item>
              <p><bold>Confirmatory finding.</bold> Absent response to TRH stimulation</p>
            </list-item>
          </list>
          <p>
            <bold>Adrenocorticotropic hormone (ACTH) deficiency</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>
                <bold>Suggestive findings</bold>
              </p>
              <list list-type="bullet">
                <list-item>
                  <p>Low serum concentration of sodium and glucose and elevated serum concentration of potassium in an acutely ill individual</p>
                </list-item>
                <list-item>
                  <p>Serum ACTH concentration that is inappropriately low in the face of a low serum concentration of cortisolNote: Blood sample for the ACTH assay needs to be collected properly and processed rapidly.</p>
                </list-item>
                <list-item>
                  <p>Normal renin-aldosterone axis</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Confirmatory finding.</bold> Subnormal increase in serum ACTH concentration in response to CRH (corticotropin releasing hormone), suggesting a pituitary etiology of ACTH deficiency. Note: Insulin-induced hypoglycemia may also be used, but a subnormal response could indicate a hypothalamic or a pituitary cause.</p>
            </list-item>
          </list>
          <sec id="prop1.Molecular_Genetic_Testing">
            <title>Molecular Genetic Testing</title>
            <p><bold>Gene.</bold>
<italic toggle="yes">PROP1</italic> is the only gene in which pathogenic variants are known to cause <italic toggle="yes">PROP1</italic>-related CPHD.</p>
            <p>
              <bold>Clinical testing</bold>
            </p>
            <table-wrap id="prop1.T.summary_of_molecular_genetic_tes" position="anchor" orientation="portrait">
              <label>Table 1. </label>
              <caption>
                <p>Summary of Molecular Genetic Testing Used in <italic toggle="yes">PROP1</italic>-Related Combined Pituitary Hormone Deficiency</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_prop1.T.summary_of_molecular_genetic_tes_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_prop1.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                    <th id="hd_h_prop1.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant Detectable by This Method</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_prop1.T.summary_of_molecular_genetic_tes_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">PROP1</italic>
                    </td>
                    <td headers="hd_h_prop1.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>2,&#x000a0;3</sup></td>
                    <td headers="hd_h_prop1.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;98%&#x000a0;<sup>4</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_prop1.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>5</sup></td>
                    <td headers="hd_h_prop1.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">See footnote 6</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="prop1.TF.1.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="prop1" object-id="prop1.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="prop1.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
                </fn>
                <fn id="prop1.TF.1.2">
                  <label>2. </label>
                  <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="prop1.TF.1.3">
                  <label>3. </label>
                  <p>The common recurring <italic toggle="yes">PROP1</italic> deletion in which three AG repeats are reduced to two AG repeats (c.301_302delAG) accounts for 55% of alleles in familial cases and 12% of alleles in simplex cases of CPHD (i.e., single occurrence in a family).</p>
                </fn>
                <fn id="prop1.TF.1.4">
                  <label>4. </label>
                  <p>The proportion of CPHD caused by pathogenic variants in <italic toggle="yes">PROP1</italic> varies by study suggesting either bias in ascertainment in some studies or variation in the frequency of <italic toggle="yes">PROP1</italic> pathogenic variants between populations of different ethnic origins [reviewed in <xref ref-type="bibr" rid="prop1.REF.de_graaff.2010.363">de Graaff et al 2010</xref>]. See <xref ref-type="table" rid="prop1.T.prop1_pathogenic_variant_detecti">Table 2</xref>.</p>
                </fn>
                <fn id="prop1.TF.1.5">
                  <label>5. </label>
                  <p>Testing that identifies exon or whole-gene deletions/duplications not detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA. Included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
                </fn>
                <fn id="prop1.TF.1.6">
                  <label>6. </label>
                  <p><xref ref-type="bibr" rid="prop1.REF.abr_o.2006.294">Abr&#x000e3;o et al [2006]</xref> reported complete deletion of <italic toggle="yes">PROP1</italic> in two sibs with GH deficiency associated with other pituitary hormone deficiencies (TSH, PRL and gonadotropins). One of the sibs also had an evolving cortisol deficiency. <xref ref-type="bibr" rid="prop1.REF.kelberman.2009.96">Kelberman et al [2009]</xref> identified a homozygous deletion of <italic toggle="yes">PROP1</italic> in two individuals with CPHD born to consanguineous parents. <xref ref-type="bibr" rid="prop1.REF.zhang.2010.98">Zhang et al [2010]</xref> reported in two pedigrees with CPHD a deletion of a segment of about 53.2 kb encompassing <italic toggle="yes">PROP1</italic> and adjacent sequences.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
        </sec>
        <sec id="prop1.Testing_Strategy">
          <title>Testing Strategy</title>
          <p>
            <bold>To confirm/establish the diagnosis in a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Growth hormone (GH) deficiency must be present.</p>
            </list-item>
            <list-item>
              <p>The order in which TSH, LH, FSH, PrL, and ACTH secretion is assessed depends on the findings in the individual.</p>
            </list-item>
            <list-item>
              <p>Molecular genetic testing</p>
              <list list-type="bullet">
                <list-item>
                  <p>In individuals with GH deficiency and at least one other pituitary hormone deficiency, molecular genetic testing of <italic toggle="yes">PROP1</italic> (first by sequence analysis followed by deletion/duplication analysis if no or only one <italic toggle="yes">PROP1</italic> pathogenic variant is identified) is indicated to establish the diagnosis of <italic toggle="yes">PROP1</italic>-related CPHD. The likelihood of CPHD being <italic toggle="yes">PROP1</italic>-related CPHD varies by study suggesting either bias in ascertainment in some studies or variation in the frequency of <italic toggle="yes">PROP1</italic> pathogenic variants between populations of different ethnic origins. In several international centers (UK, India, and Poland), <italic toggle="yes">PROP1</italic> pathogenic variants were identified in almost 30% of familial cases and only 1%-2% of simplex cases [<xref ref-type="bibr" rid="prop1.REF.turton.2005.10">Turton et al 2005</xref>]. <xref ref-type="table" rid="prop1.T.prop1_pathogenic_variant_detecti">Table 2</xref> summarizes the <italic toggle="yes">PROP1</italic> pathogenic variant frequencies in persons with CPHD from several published articles.</p>
                </list-item>
                <list-item>
                  <p>For individuals with CPHD in whom no <italic toggle="yes">PROP1</italic> pathogenic variant is identified, consider testing other genes in which pathogenic variants are known to cause CPHD. Use of a multi-gene panel may be appropriate (see <xref ref-type="sec" rid="prop1.Differential_Diagnosis">Differential Diagnosis</xref>).</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <table-wrap id="prop1.T.prop1_pathogenic_variant_detecti" position="anchor" orientation="portrait">
            <label>Table 2. </label>
            <caption>
              <p><italic toggle="yes">PROP1</italic> Pathogenic Variant Detection Frequency in Cohorts with CPHD</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference</th>
                  <th id="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Simplex / Familial Cases</th>
                  <th id="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">N Patients</th>
                  <th id="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">N Families</th>
                  <th id="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">N Pathogenic Variants / N Tested</th>
                  <th id="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Origin</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="prop1.REF.dateki.2010.4043">Dateki et al [2010]</xref>
                  </td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">71</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Japanese</td>
                </tr>
                <tr>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="prop1.REF.diaczok.2008.4351">Diaczok et al [2008]</xref>
                  </td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">19</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                </tr>
                <tr>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="prop1.REF.de_graaff.2010.363">De Graaff et al [2010]</xref>
                  </td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Mostly simplex</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">78</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">76</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Dutch</td>
                </tr>
                <tr>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="prop1.REF.mclennan.2003.785">McLennan et al [2003]</xref>
                  </td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Simplex</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">33</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Australian</td>
                </tr>
                <tr>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="prop1.REF.kim.2003.277">Kim et al [2003]</xref>
                  </td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Simplex</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">12</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Korean</td>
                </tr>
                <tr>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="prop1.REF.rainbow.2005.163">Rainbow et al [2005]</xref>
                  </td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Mostly simplex</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">27</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">26</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">UK</td>
                </tr>
                <tr>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="prop1.REF.fernandezrodriguez.2011.181">Fernandez-Rodriguez et al [2011]</xref>
                  </td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Mixed simplex and familial</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">23</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">2/23</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Spanish</td>
                </tr>
                <tr>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="prop1.REF.turton.2005.10">Turton et al [2005]</xref>
                  </td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Mixed simplex and familial</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">153</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">15</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Various</td>
                </tr>
                <tr>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="prop1.REF.osorio.2002.5076">Osorio et al [2002]</xref>
                  </td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Mostly simplex</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">76</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">74</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">5/43</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Brazilian</td>
                </tr>
                <tr>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="prop1.REF.navardauskaite.2014.299">Navardauskaite et al [2014]</xref>
                  </td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Mixed simplex and familial</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">67</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">NA<sup>1</sup></td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">47/67</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Lithuania</td>
                </tr>
                <tr>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="prop1.REF.nystr_m.2011.208">Nystr&#x000f6;m et al [2011]</xref>
                  </td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Mixed</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">25</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">23</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">2/17</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                </tr>
                <tr>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="prop1.REF.reynaud.2006.3329">Reynaud et al [2006]</xref>
                  </td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Mixed</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">195</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">165</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">20/109</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Various</td>
                </tr>
                <tr>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="prop1.REF.lebl.2005.389">Lebl et al [2005]</xref>
                  </td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Mostly simplex</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">74</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">NA&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">18/74</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Czech</td>
                </tr>
                <tr>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="prop1.REF.zimmermann.2007.587">Zimmermann et al [2007]</xref>
                  </td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Mixed simplex and familial</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">17</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">5/17</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                </tr>
                <tr>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="prop1.REF.vieira.2007.1097">Vieira et al [2007]</xref>
                  </td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Mixed</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">40</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">36</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">9/26</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Brazilian</td>
                </tr>
                <tr>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="prop1.REF.vallettekasic.2001.4529">Vallette-Kasic et al [2001]</xref>
                  </td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Mostly simplex</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">23</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">20</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">9/23&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Various</td>
                </tr>
                <tr>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="prop1.REF.lemos.2006.479">Lemos et al [2006]</xref>
                  </td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Mixed</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">46</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">See footnote 4</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">19</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Portuguese</td>
                </tr>
                <tr>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="prop1.REF.hal_sz.2006.255">Hal&#x000e1;sz et al [2006]</xref>
                  </td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">35</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">15/35</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Hungarian</td>
                </tr>
                <tr>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="prop1.REF.delado_y.1999.1645">Delado&#x000eb;y et al [1999]</xref>
                  </td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Familial</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">73</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">36</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">35/73&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                </tr>
                <tr>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="prop1.REF.fofanova.1998.45">Fofanova et al [1998]</xref>
                  </td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Mixed</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">14</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">See footnote 5</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">8/14</td>
                  <td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Russian</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p><italic toggle="yes">PROP1</italic> pathogenic variant frequencies reported in CPHD populations (Studies that investigated cohorts mixed isolated growth hormone deficiency (IGHD) and CPHD are not included.)</p>
              </fn>
              <fn id="prop1.TF.2.1">
                <label>1. </label>
                <p>67 affected individuals, including nine sibling pairs and two sibling triplets</p>
              </fn>
              <fn id="prop1.TF.2.2">
                <label>2. </label>
                <p>Including 4 sib pairs</p>
              </fn>
              <fn id="prop1.TF.2.3">
                <label>3. </label>
                <p>Same pathogenic variant found in more than one individual from a given family</p>
              </fn>
              <fn id="prop1.TF.2.4">
                <label>4. </label>
                <p>17 familial cases from seven families; 29 simplex cases</p>
              </fn>
              <fn id="prop1.TF.2.5">
                <label>5. </label>
                <p>Seven familial cases from four families; seven simplex cases</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="prop1.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="prop1.Clinical_Description">
          <title>Clinical Description</title>
          <p><italic toggle="yes">PROP1</italic> pathogenic variants are associated with deficiencies of growth hormone (GH), thyroid-stimulating hormone (TSH), gonadotropins (FSH and LH), prolactin (PrL), and adrenocorticotropic hormone (ACTH). The secretion of all these pituitary-derived hormones declines gradually with age; often the order of appearance of hormone deficiency is GH, LH and FSH, TSH, and ACTH.</p>
          <p>The degree of hormone deficiency and the age of onset of the deficiency are variable even within the same family. In a follow-up study of nine individuals with <italic toggle="yes">PROP1</italic> pathogenic variants, all seven who had reached the age of puberty required sex hormone replacement therapy (HRT). Repeated testing of pituitary function indicated a decline over time; all individuals developed some degree of adrenal insufficiency [<xref ref-type="bibr" rid="prop1.REF.bottner.2004.5256">Bottner et al 2004</xref>].</p>
          <p><bold>GH deficiency</bold>. Children with <italic toggle="yes">PROP1</italic>-related CPHD are often ascertained because of short stature. Most affected children have normal birth weight and birth length and an uncomplicated perinatal period. Growth failure and failure to thrive begin in infancy or early childhood (range: ~9 months to ~8 years).</p>
          <p>Individuals with <italic toggle="yes">PROP1</italic>-related CPHD who have untreated growth hormone deficiency have proportional short stature (i.e., &#x0003c;4 cm difference between length of arm span and height) with proportionately small hands and feet. Height is usually profoundly reduced, with SD scores of more than -3.7 [<xref ref-type="bibr" rid="prop1.REF.bottner.2004.5256">Bottner et al 2004</xref>, <xref ref-type="bibr" rid="prop1.REF.reynaud.2004.5779">Reynaud et al 2004</xref>].</p>
          <p>In newborn infants, the primary manifestation may be hypoglycemia.</p>
          <p><bold>TSH deficiency.</bold> Rarely, hypothyroidism is the presenting finding [<xref ref-type="bibr" rid="prop1.REF.fl_ck.1998.3727">Fl&#x000fc;ck et al 1998</xref>]. Hypothyroidism is usually mild and occurs in later infancy and childhood. Since it is usually not congenital or severe, it is not associated with intellectual disability.</p>
          <p><bold>FSH and LH deficiency.</bold> Affected individuals can have absent or delayed and incomplete secondary sexual development with infertility.</p>
          <list list-type="bullet">
            <list-item>
              <p>Untreated males usually have a small penis and small testes.</p>
            </list-item>
            <list-item>
              <p>Some females experience menarche before requiring hormone replacement therapy [<xref ref-type="bibr" rid="prop1.REF.fl_ck.1998.3727">Fl&#x000fc;ck et al 1998</xref>].</p>
            </list-item>
          </list>
          <p>In some individuals, apparently <related-object link-type="booklink" source-id="gene" document-id="kms" document-type="chapter">isolated gonadotropin deficiency</related-object> may be the presenting finding: in one family two brothers were thought to have isolated hypogonadotropic hypogonadism until they developed GH deficiency and TSH deficiency after age 30 years; at that time CPHD was diagnosed [<xref ref-type="bibr" rid="prop1.REF.reynaud.2005.4880">Reynaud et al 2005</xref>].</p>
          <p><bold>PrL deficiency.</bold> Prolactin deficiency generally causes few symptoms, as prolactin is only required at the time of breastfeeding.</p>
          <p><bold>ACTH deficiency.</bold> It was initially thought that ACTH deficiency was uncommon and, when present, usually occurred in adolescence or adulthood; however, longer follow up has shown that some degree of adrenal failure may occur in most individuals with <italic toggle="yes">PROP1</italic> pathogenic variants [<xref ref-type="bibr" rid="prop1.REF.bottner.2004.5256">Bottner et al 2004</xref>].</p>
          <p><bold>CPHD</bold>. Severe deficiency of GH and insulin-like growth factor 1 (IGF-1), especially when combined with hypothyroidism and absence of secondary sexual development, are associated with significant growth failure. In one Brazilian family in which eight individuals had this combination of findings; adult heights ranged from 5.9 to 9.6 SD below the mean [<xref ref-type="bibr" rid="prop1.REF.pernasetti.2000.390">Pernasetti et al 2000</xref>].</p>
          <p>
            <bold>Other findings</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>An 8&#x000b0; to 20&#x000b0; limitation of extension of the elbows that increases with age has been observed.</p>
            </list-item>
            <list-item>
              <p>Facies are characterized as "immature," with a depressed nasal bridge and relative decrease in the vertical dimensions of the face [<xref ref-type="bibr" rid="prop1.REF.pirinen.1994.144">Pirinen et al 1994</xref>].</p>
            </list-item>
            <list-item>
              <p>Obesity, rare in childhood, is more common in adulthood.</p>
            </list-item>
            <list-item>
              <p>Intelligence is usually normal.</p>
            </list-item>
          </list>
          <p><bold>Imaging studies.</bold> The pituitary may initially appear diffusely enlarged in childhood and then reduced in size in adolescence or adulthood [<xref ref-type="bibr" rid="prop1.REF.mendonca.1999.942">Mendonca et al 1999</xref>, <xref ref-type="bibr" rid="prop1.REF.riepe.2001.4353">Riepe et al 2001</xref>, <xref ref-type="bibr" rid="prop1.REF.reynaud.2004.5779">Reynaud et al 2004</xref>, <xref ref-type="bibr" rid="prop1.REF.tatsumi.2004.635">Tatsumi et al 2004</xref>, <xref ref-type="bibr" rid="prop1.REF.voutetakis.2004a.2200">Voutetakis et al 2004a</xref>, <xref ref-type="bibr" rid="prop1.REF.voutetakis.2004b.257">Voutetakis et al 2004b</xref>].</p>
          <p>The sella turcica may be normal in size or enlarged, or may appear "empty."</p>
        </sec>
        <sec id="prop1.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>No correlation has been observed between the different <italic toggle="yes">PROP1</italic> pathogenic variants and the phenotype of the affected individual.</p>
        </sec>
        <sec id="prop1.Penetrance">
          <title>Penetrance</title>
          <p>The clinical phenotype of <italic toggle="yes">PROP1</italic>-related CPHD is variable, even among individuals with the same pathogenic variants. Variation is observed in the age at diagnosis and the severity of findings resulting from deficiencies of GH, TSH, LH, FSH, and PrL [<xref ref-type="bibr" rid="prop1.REF.fl_ck.1998.3727">Fl&#x000fc;ck et al 1998</xref>].</p>
          <p>Anterior pituitary function including adrenal function can deteriorate over time such that penetrance is age dependent.</p>
        </sec>
        <sec id="prop1.Prevalence">
          <title>Prevalence</title>
          <p>The frequency of pituitary dwarfism is estimated at 1:4000 in England and the US. The proportion of individuals with pituitary dwarfism who have CPHD ranges from 43% to 63%, suggesting a frequency of approximately 1:8000 for CPHD.</p>
        </sec>
      </sec>
      <sec id="prop1.Genetically_Related_Allelic_Disord">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with mutation of <italic toggle="yes">PROP1.</italic></p>
      </sec>
      <sec id="prop1.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>See <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/phenotypicSeries/PS613038">Pituitary Hormone Deficiency, Combined: OMIM Phenotypic Series</ext-link>, a table of similar phenotypes that are genetically diverse.</p>
        <p>While short stature, delayed growth velocity, and delayed skeletal maturation are all seen with GH deficiency, none of these manifestations is specific for GH deficiency; therefore, individuals with these findings should be evaluated for other, systemic diseases associated with short stature before doing provocative tests to document GH deficiency.</p>
        <sec id="prop1.Combined_Pituitary_Hormone_Deficie">
          <title>Combined Pituitary Hormone Deficiencies (CPHD)</title>
          <p>Whereas many individuals with pituitary dwarfism have a craniopharyngioma or other non-genetic cause, 7% to 12% of individuals have an affected first-degree relative, suggesting that many cases are the result of genetic factors [<xref ref-type="bibr" rid="prop1.REF.phillips.1995">Phillips 1995</xref>].</p>
          <p>Familial CPHD can be inherited in an autosomal recessive, autosomal dominant, or X-linked recessive manner. To date, <italic toggle="yes">PROP1</italic>, <italic toggle="yes">POU1F1</italic> (formerly <italic toggle="yes">PIT1</italic>), <italic toggle="yes">HESX1</italic>, <italic toggle="yes">LHX3</italic>, and <italic toggle="yes">LHX4</italic> have been associated with familial CPHD [<xref ref-type="bibr" rid="prop1.REF.dattani.1998.125">Dattani et al 1998</xref>, <xref ref-type="bibr" rid="prop1.REF.dattani.2003">Dattani 2003</xref>, <xref ref-type="bibr" rid="prop1.REF.kim.2003.277">Kim et al 2003</xref>, <xref ref-type="bibr" rid="prop1.REF.mclennan.2003.785">McLennan et al 2003</xref>, <xref ref-type="bibr" rid="prop1.REF.reynaud.2004.5779">Reynaud et al 2004</xref>].</p>
          <p>Although genetic alterations of a specific gene are associated with a &#x02018;typical&#x02019; phenotype, variability in the onset and extent of clinical manifestations can be observed. Depending on the gene involved, pituitary manifestations may range from normal pituitary function to complete pan-hypopituitarism and from normal height to severe growth retardation.</p>
          <p>For the clinician this means that continuous monitoring of the hormonal state of the patient until adulthood is mandatory to avoid late-onset complications. For the geneticist it means that the type of hormone deficiencies, the extra-pituitary manifestations and the family history give valuable information for a specific genetic workup, but that additional &#x02018;atypical&#x02019; genes have to be considered if the initial analysis fails to detect a pathogenic variant in the &#x02018;first-choice&#x02019; candidate genes [<xref ref-type="bibr" rid="prop1.REF.pf_ffle.2011.43">Pf&#x000e4;ffle &#x00026; Klammt 2011</xref>].</p>
          <p><bold><italic toggle="yes">PROP1.</italic></bold>
<xref ref-type="bibr" rid="prop1.REF.bottner.2004.5256">Bottner et al [2004]</xref> concluded that 50% of CPHD has a genetic basis and that half of familial cases are caused by <italic toggle="yes">PROP1</italic> pathogenic variants; however, more recent data demonstrate that this is not the situation for simplex cases (see <xref ref-type="table" rid="prop1.T.prop1_pathogenic_variant_detecti">Table 2</xref>).</p>
          <p><bold><italic toggle="yes">POU1F1</italic> (formerly <italic toggle="yes">PIT1</italic>).</bold> Pathogenic variants of <italic toggle="yes">POU1F1</italic> causing CPHD can be inherited in either an autosomal recessive or autosomal dominant manner.</p>
          <p><italic toggle="yes">POU1F1</italic> variants are associated with deficiencies of growth hormone and prolactin and variable deficiency of the &#x003b2; subunit of TSH. Of note, <italic toggle="yes">POU1F1</italic> variants are also associated with isolated growth hormone deficiency [<xref ref-type="bibr" rid="prop1.REF.dattani.2003">Dattani 2003</xref>].</p>
          <p>Most affected individuals have normal birth weight and birth length and an uncomplicated perinatal course. Growth hormone deficiency is usually severe and most individuals have growth failure in early infancy.</p>
          <p>Hypothyroidism can be congenital, or mild and later in onset; progressive loss of TSH occurs over time.</p>
          <p>Affected individuals have proportional short stature and distinctive facies characterized by prominent forehead, marked midface hypoplasia with depressed nasal bridge, deep-set eyes, and short nose with anteverted nostrils [<xref ref-type="bibr" rid="prop1.REF.aarskog.1997.829">Aarskog et al 1997</xref>].</p>
          <p>The pituitary usually appears hypoplastic on imaging studies.</p>
          <p>For more information about specific <italic toggle="yes">POU1F1</italic> variants, click <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="prop1-POU1F1_variants.pdf" content-type="local-data">here</inline-supplementary-material>.</p>
          <p><bold><italic toggle="yes">HESX1.</italic></bold> Pathogenic variants in <italic toggle="yes">HESX1</italic> have been identified with both autosomal dominant and autosomal recessive inheritance of CPHD [<xref ref-type="bibr" rid="prop1.REF.cohen.2003.4832">Cohen et al 2003</xref>], sometimes combined with septooptic dysplasia (SOD). Affected individuals may present with isolated growth hormone deficiency (IGHD) [<xref ref-type="bibr" rid="prop1.REF.vivenza.2011.705">Vivenza et al 2011</xref>].</p>
          <p>Affected individuals have midline defects, optic nerve hypoplasia, neuro-pituitary ectopia, and pituitary hypoplasia associated with hormonal deficiencies [<xref ref-type="bibr" rid="prop1.REF.mcnay.2007.691">McNay et al 2007</xref>].</p>
          <p><italic toggle="yes">HESX1</italic> is expressed in the thickened layer of oral ectoderm that gives rise to the Rathke pouch, the primordium of the anterior pituitary. Downregulation of <italic toggle="yes">HESX1</italic> coincides with the differentiation of pituitary-specific cell types.</p>
          <p>For information on specific <italic toggle="yes">HESX1</italic> variants, click <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="prop1-HESX1_variants.pdf" content-type="local-data">here</inline-supplementary-material>.</p>
          <p><bold><italic toggle="yes">LHX3</italic> and <italic toggle="yes">LHX4.</italic></bold> LHX3 and LHX4 are members of the LIM-homeodomain family of transcription factors. Together, they regulate proliferation and differentiation of pituitary-specific cell lineages.</p>
          <p><bold><italic toggle="yes">LHX3,</italic></bold> comprising seven coding exons and six introns that span 8.7 kilobases, is located in the subtelomeric region of chromosome 9. Several <italic toggle="yes">LHX3</italic> variants have been described to date. For a comprehensive review, see <xref ref-type="bibr" rid="prop1.REF.pf_ffle.2011.43">Pf&#x000e4;ffle &#x00026; Klammt [2011]</xref></p>
          <p>For information on specific <italic toggle="yes">LHX3</italic> variants, click <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="prop1-LHX3_variants.pdf" content-type="local-data">here</inline-supplementary-material>.</p>
          <p><bold><italic toggle="yes">LHX4</italic></bold> extends over approximately 45 kb on chromosome 1. Heterozygous variants in <italic toggle="yes">LHX4</italic> are associated with CPHD along with congenital defects in the cerebellum and sella turcica. Several <italic toggle="yes">LHX4</italic> variants have been described to date. For a comprehensive review, see <xref ref-type="bibr" rid="prop1.REF.pf_ffle.2011.43">Pf&#x000e4;ffle &#x00026; Klammt [2011]</xref>.</p>
          <p>For information on specific <italic toggle="yes">LHX4</italic> variants, click <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="prop1-LHX4_variants.pdf" content-type="local-data">here</inline-supplementary-material>.</p>
        </sec>
        <sec id="prop1.Isolated_Growth_Hormone_Deficiency">
          <title>Isolated Growth Hormone Deficiency</title>
          <p>CPHD needs to be differentiated from isolated growth hormone deficiency (IGHD).</p>
          <p>
            <bold><italic toggle="yes">GH1-</italic>related IGHD</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>IGHD IA and IB are inherited in an autosomal recessive manner.</p>
              <list list-type="bullet">
                <list-item>
                  <p>In IGHD 1A, <italic toggle="yes">GH1</italic> deletions, frameshifts, and nonsense variants lead to GH deficiency with severe growth failure; affected individuals often develop anti-GH antibodies when given exogenous GH.</p>
                </list-item>
                <list-item>
                  <p>In IGHD IB, <italic toggle="yes">GH1</italic> splice site variants are responsible for low (but detectable) levels of GH. Growth failure is less severe than in IGHD IA, and individuals usually respond well to exogenous GH.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>IGHD II is inherited in an autosomal dominant manner. Splice site or missense <italic toggle="yes">GH1</italic> variants have a dominant-negative effect. The clinical severity of IGHD II varies across kindreds. Affected individuals usually respond well to exogenous GH.</p>
            </list-item>
          </list>
        </sec>
        <sec id="prop1.Isolated_Hypogonadotropic_Hypogona">
          <title>Isolated Hypogonadotropic Hypogonadism</title>
          <p>In one family two brothers with <italic toggle="yes">PROP1</italic>-related CPHD were thought to have <related-object link-type="booklink" source-id="gene" document-id="kms" document-type="chapter">hypogonadotropic hypogonadism</related-object> until they developed GH deficiency and TSH deficiency after age 30 years [<xref ref-type="bibr" rid="prop1.REF.reynaud.2005.4880">Reynaud et al 2005</xref>]. Their findings demonstrate that <italic toggle="yes">PROP1</italic> variants should also be considered among possible genetic causes of apparently isolated hypogonadotropic hypogonadism.</p>
        </sec>
        <sec id="prop1.Syndromes_that_Include_Hypopituita">
          <title>Syndromes that Include Hypopituitarism</title>
          <p>Variants in the following genes have been studied in syndromes that include hypopituitarism [<xref ref-type="bibr" rid="prop1.REF.roessler.2003.13424">Roessler et al 2003</xref>, <xref ref-type="bibr" rid="prop1.REF.kelberman.2007.s3">Kelberman &#x00026; Dattani 2007</xref>, <xref ref-type="bibr" rid="prop1.REF.ashkenazihoffnung.2010.721">Ashkenazi-Hoffnung et al 2010</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold><italic toggle="yes">SOX2</italic></bold> variants observed with: hypogonadotropic hypogonadism; anterior pituitary hypoplasia; bilateral anophthalmia/microphthalmia; abnormal corpus callosum; learning difficulties; esophageal atresia; and/or sensorineural hearing loss (See <related-object link-type="booklink" source-id="gene" document-id="anophthalmia-ov" document-type="chapter">Anophthalmia/Microphthalmia Overview</related-object>, <related-object link-type="booklink" source-id="gene" document-id="sox2" document-type="chapter"><italic toggle="yes">SOX2</italic>-Related Eye Disorders</related-object>.)</p>
            </list-item>
            <list-item>
              <p><bold><italic toggle="yes">SOX3</italic></bold> variants observed with: X-linked anterior pituitary hypoplasia with IGHD or panhypopituitarism; infundibular hypoplasia and/or ectopic posterior pituitary; intellectual disability [<xref ref-type="bibr" rid="prop1.REF.solomon.2004.669">Solomon et al 2004</xref>, <xref ref-type="bibr" rid="prop1.REF.woods.2005.833">Woods et al 2005</xref>]</p>
            </list-item>
            <list-item>
              <p><bold><italic toggle="yes">OTX2</italic></bold> variants observed with isolated growth hormone deficiency (IGHD) with small anterior pituitary gland, invisible stalk, ectopic posterior lobe, and anophthalmia [<xref ref-type="bibr" rid="prop1.REF.diaczok.2008.4351">Diaczok et al 2008</xref>]</p>
            </list-item>
            <list-item>
              <p><bold><italic toggle="yes">GLI2</italic></bold> variants observed with <related-object link-type="booklink" source-id="gene" document-id="hpe-overview" document-type="chapter">holoprosencephaly</related-object>, abnormal pituitary gland function, and variable craniofacial abnormalities. Other features included postaxial polydactyly, single nares, single central incisor, and partial agenesis of the corpus callosum [<xref ref-type="bibr" rid="prop1.REF.roessler.2003.13424">Roessler et al 2003</xref>].</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec id="prop1.Management">
        <title>Management</title>
        <sec id="prop1.Evaluations_Following_Initial_Diag">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in each individual with newly diagnosed <italic toggle="yes">PROP1</italic>-related combined pituitary hormone deficiency (CPHD), it is important to evaluate for deficiencies of GH, TSH, LH, FSH, PRL, and ACTH because treatment of one hormone deficiency can precipitate symptoms of another hormone deficiency:</p>
          <list list-type="bullet">
            <list-item>
              <p>A total T<sub>4</sub> assay can be used to evaluate thyroid hormone production.</p>
            </list-item>
            <list-item>
              <p>Evaluation of LH and FSH production is more relevant in postpubertal individuals, particularly if sexual development is incomplete or if women display hypoestrogenic amenorrhea.</p>
            </list-item>
            <list-item>
              <p>AM cortisol can be used to evaluate adrenal hormone production.</p>
            </list-item>
          </list>
          <p>Medical genetics consultation is appropriate.</p>
        </sec>
        <sec id="prop1.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>The main principle of treatment in CPHD is replacement therapy with the appropriate hormones [<xref ref-type="bibr" rid="prop1.REF.mehta.2009">Mehta et al 2009</xref>].</p>
          <p><bold>Growth hormone.</bold> GH deficiency is treated by subcutaneous injection of biosynthetic (i.e., recombinant) GH. To obtain an optimal outcome, replacement therapy should be started as soon as the diagnosis of GH deficiency is established. The initial dose of recombinant human GH (rhGH) is based on body weight, but the exact dose and the frequency of administration vary by protocol. The dose increases with increasing body weight to a maximum during puberty and is usually discontinued when final height has been reached, at approximately age 17 years [<xref ref-type="bibr" rid="prop1.REF.ranke.1995.122">Ranke 1995</xref>, <xref ref-type="bibr" rid="prop1.REF.ros_n.1995.93">Ros&#x000e9;n et al 1995</xref>, Growth Hormone Research Society 2000 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://jcem.endojournals.org/content/85/11/3990.long">full text</ext-link>)].</p>
          <p>There is increasing support for the use of rhGH treatment in young adults with GHD as well because of the possible effects on fat metabolism, lean body mass, and bone mineral density [Ho et al 2007 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ghresearchsociety.org/files/2007_Consensus_AGHD.pdf">full text</ext-link>)].</p>
          <p>Clinical response to exogenous GH usually depends on the etiology and severity of the GH deficiency, deficiencies of other pituitary hormones, age of onset of growth failure, the time interval between the onset of growth failure and the onset of GH therapy, duration of replacement therapy, and the sex of the affected individual [<xref ref-type="bibr" rid="prop1.REF.blethen.1997.418">Blethen et al 1997</xref>]. <xref ref-type="bibr" rid="prop1.REF.de_ridder.2007.925">De Ridder et al [2007]</xref> developed a model that accurately predicts the adult height that will be achieved by GH therapy.</p>
          <p><bold>TSH.</bold> TSH deficiency is treated by thyroid hormone replacement in the form of L-thyroxine at a dose of approximately 1-3 &#x000b5;g/kg/day given orally. Of note, thyroid hormone replacement should not be initiated until adrenal function has been assessed and adrenal insufficiency is treated if present.</p>
          <p>
            <bold>LH and FSH</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Male infants with micropenis are treated with 50 mg testosterone enanthate intramuscularly every four weeks for a total of three to four doses.</p>
            </list-item>
            <list-item>
              <p>If GH deficiency is present and if the child's growth normalizes before adolescence, it is appropriate to begin sex steroid replacement to induce secondary sex characteristics.</p>
              <list list-type="bullet">
                <list-item>
                  <p>In males, this can be initiated at age 12 to 13 years with monthly injections of 100 mg testosterone enanthate, gradually increasing by 50 mg every six months to a dose of 200 to 300 mg per month.</p>
                </list-item>
                <list-item>
                  <p>In females, this can be initiated at age 11 to 12 years with conjugated estrogens or ethinyl estradiol, eventually cycling with estrogen and progesterone.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>If the child has untreated growth hormone deficiency, the sex hormone replacement is given in lower doses and started at a later age to ensure maximal growth before epiphyseal closure.</p>
            </list-item>
            <list-item>
              <p>Usually sex steroids are used to maintain secondary sex characteristics.</p>
            </list-item>
            <list-item>
              <p>Fertility in both females and males is possible with administration of gonadotropins [<xref ref-type="bibr" rid="prop1.REF.voutetakis.2004c.454">Voutetakis et al 2004c</xref>]. Note: Because infertility in individuals with <italic toggle="yes">PROP1</italic>-related CPHD is secondary to hypogonadotropic hypogonadism, appropriate treatment consists of gonadotropin replacement rather than the use of clomiphene citrate, which requires an intact pituitary gland.</p>
            </list-item>
          </list>
          <p><bold>ACTH.</bold> Long-term management is usually 10-15 mg/M<sup>2</sup> oral hydrocortisone per 24 hours divided into three doses.</p>
          <list list-type="bullet">
            <list-item>
              <p>For individuals with GH deficiency, the lowest safe dose of hydrocortisone is used to avoid interfering with the growth response to growth hormone therapy.</p>
            </list-item>
            <list-item>
              <p>For minor stress such as fever or minor illness, the dose of hydrocortisone is doubled or tripled until the illness has resolved.</p>
            </list-item>
            <list-item>
              <p>For major stress, such as surgery or significant illness, hydrocortisone is increased to 40 to 100 mg/M<sup>2</sup> and administered parenterally.</p>
            </list-item>
          </list>
        </sec>
        <sec id="prop1.Surveillance">
          <title>Surveillance</title>
          <p>Growth should be carefully monitored; if growth velocity is low, evaluation for GH deficiency should be undertaken.</p>
          <p>In persons with <italic toggle="yes">PROP1</italic> pathogenic variants without known ACTH deficiency, cortisol levels should be monitored because ACTH deficiency may develop at a later time.</p>
        </sec>
        <sec id="prop1.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>If both (paternal and maternal) <italic toggle="yes">PROP1</italic> pathogenic variants are identified in a proband, it is appropriate to perform molecular genetic testing on younger sibs to enable early diagnosis and treatment.</p>
          <p>For younger sibs who have not undergone molecular genetic testing, monitoring growth for evidence of growth failure is appropriate. Of note, affected sibs usually have extreme short stature because of thyroid hormone deficiency and growth hormone deficiency.</p>
          <p>See <xref ref-type="sec" rid="prop1.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="prop1.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="prop1.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="prop1.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p><italic toggle="yes">PROP1</italic>-related combined pituitary hormone deficiency is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="prop1.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected child are obligate heterozygotes (i.e., carriers of one mutant allele).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes are asymptomatic.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Once an at-risk sib is known to be unaffected, the chance of his/her being a carrier is 2/3.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic.</p>
            </list-item>
          </list>
          <p>
            <bold>Offspring of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Fertility is reduced in individuals with <italic toggle="yes">PROP1</italic>-related CPHD.</p>
            </list-item>
            <list-item>
              <p>If an individual with <italic toggle="yes">PROP1</italic>-related CPHD were fertile, each offspring would be an obligate heterozygote (carrier) for a pathogenic variant in <italic toggle="yes">PROP1</italic>.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes are asymptomatic.</p>
            </list-item>
          </list>
          <p><bold>Other family members of a proband.</bold> Each sib of the proband's parents is at a 50% risk of being a carrier.</p>
        </sec>
        <sec id="prop1.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>Carrier testing is possible if the <italic toggle="yes">PROP1</italic> pathogenic variants have been identified in the family.</p>
        </sec>
        <sec id="prop1.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="prop1.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="prop1.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p>If the pathogenic variants have been identified in an affected family member, prenatal testing for pregnancies at increased risk may be available from a clinical laboratory that offers either testing for this disease/gene or custom prenatal testing.</p>
          <p>Requests for prenatal testing for conditions which (like <italic toggle="yes">PROP1</italic>-related combined pituitary hormone deficiency) do not affect intellect and are associated with a good prognosis with early treatment are not common. Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the pathogenic variants have been identified.</p>
        </sec>
      </sec>
      <sec id="prop1.Resources">
        <title>Resources</title>
      </sec>
      <sec id="prop1.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">PROP1</italic> comprises three exons of 418, 233, and 339 bp and spans 3.54 kb. Transcripts are 1464 nucleotides long. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="prop1" object-id="prop1.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic allelic variants</bold> (see <xref ref-type="table" rid="prop1.T.selected_prop1_pathogenic_varian">Table 3</xref>)</p>
        <list list-type="bullet">
          <list-item>
            <p><xref ref-type="bibr" rid="prop1.REF.wu.1998.147">Wu et al [1998]</xref> reported five families in which CPHD was caused by homozygosity or compound heterozygosity for inactivating variants of <italic toggle="yes">PROP1</italic>; these variants result in <italic toggle="yes">PROP1</italic> products with reduced DNA binding and transcriptional activation. The variant c.301_302delAG was detected on different haplotypes in families with CPHD from different countries. These data strongly suggest that the c.301_302delAG is a recurrent variant, possible resulting from DNA slippage repair defects.</p>
          </list-item>
          <list-item>
            <p><xref ref-type="bibr" rid="prop1.REF.paracchini.2003.142">Paracchini et al [2003]</xref> described two sibs with compound heterozygosity p.[Arg71Cys]+[Arg71His] in the first alpha helix of the <italic toggle="yes">PROP1</italic> homeodomain (no in vitro analysis was performed). Both had GH and TSH deficiency and short stature. One sib, who was of pubertal age, lacked breast development.</p>
          </list-item>
          <list-item>
            <p><xref ref-type="bibr" rid="prop1.REF.reynaud.2004.5779">Reynaud et al [2004]</xref> described a homozygous c.217C&#x0003e;T variant in a large, consanguineous kindred. All 12 individuals studied had complete GH deficiency. Eleven of 12 had TSH deficiency and eight of ten had ACTH deficiency. Only two females had spontaneous puberty. In vitro studies revealed that the mutant protein had 11.5% of transactivation capacity of wild type <italic toggle="yes">PROP1</italic> and was unable to bind a high-affinity DNA sequence.</p>
          </list-item>
          <list-item>
            <p><xref ref-type="bibr" rid="prop1.REF.tatsumi.2004.635">Tatsumi et al [2004]</xref> reported the first instance of <italic toggle="yes">PROP1</italic> variants causing CPHD in Japanese individuals. Two sibs presenting with early-onset growth deficiency and deficiencies of GH, TSH, PRL, and gonadotropins were homozygous for c.157delA. The protein, if translated, predicts the absence of the DNA binding domain.</p>
          </list-item>
          <list-item>
            <p><xref ref-type="bibr" rid="prop1.REF.voutetakis.2004b.257">Voutetakis et al [2004b]</xref> reported compound heterozygosity for p.Leu102CysfsTer8 (c.300_301 delGA) and a nonsense variant p.Gln83Ter (in a neonate with jaundice and congenital hypothyroidism.</p>
          </list-item>
          <list-item>
            <p><xref ref-type="bibr" rid="prop1.REF.voutetakis.2004a.2200">Voutetakis et al [2004a]</xref> reported 15 individuals (age 2.5-45 years) with a variety of different <italic toggle="yes">PROP1</italic> genotypes including:</p>
            <list list-type="bullet">
              <list-item>
                <p>Homozygosity for c.300_301delGA (7 individuals);</p>
              </list-item>
              <list-item>
                <p>Homozygosity for c.150delA (5 individuals);</p>
              </list-item>
              <list-item>
                <p>Compound heterozygosity for c.[300_301delGA]+[150delA] (2 individuals);</p>
              </list-item>
              <list-item>
                <p>Compound heterozygosity for c.[300_301delGA]+[218G&#x0003e;A] (1 individual).</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>B&#x000f6;ttner et al [2004] reported a progressive decline with age in peak levels of GH, TSH, prolactin, and LH/FSH in nine individuals with the variants c.300_301delGA, c.150delA, and/or c.109+1G&#x0003e;T. Although mutation of <italic toggle="yes">PROP1</italic> is usually not associated with ACTH deficiency, all patients developed at least partial adrenal insufficiency, with a gradual decline of the function of the pituitary adrenal axis, and eventually required treatment with hydrocortisone.</p>
          </list-item>
          <list-item>
            <p><xref ref-type="bibr" rid="prop1.REF.reynaud.2005.4880">Reynaud et al [2005]</xref> reported three brothers with hypogonadotropic hypogonadism as a result of homozygosity for the nonsense variant c.582G&#x0003e;A (p.Trp194Ter) causing premature truncation of the protein in the transactivation domain. The brothers reached normal adult height but developed GH and TSH deficiencies after age 30 years. In vitro studies revealed that the transactivation capacity of the protein was 34.4% of wild type and suggested that the C-terminal end of the protein plays a role in protein-DNA binding.</p>
          </list-item>
          <list-item>
            <p><xref ref-type="bibr" rid="prop1.REF.turton.2005.10">Turton et al [2005]</xref> described considerable phenotypic variability in siblings with CPHD, suggesting that modifying environmental or genetic factors play a role in phenotypic expression of disease. In addition, they report the variant c.112_124del as a possible founder variant from the Indian subcontinent, having identified the variant in eight individuals from five different families.</p>
          </list-item>
          <list-item>
            <p><xref ref-type="bibr" rid="prop1.REF.nose.2006.491">Nose et al [2006]</xref> described an insertion, c.467_468insT, located in the transcription-activating region of <italic toggle="yes">PROP1</italic> in two sisters with slight pituitary hypoplasia and deficiencies of growth hormone, thyroid stimulating hormone, prolactin, and gonadotropins; adrenocorticotropin secretion appeared adequate.</p>
          </list-item>
          <list-item>
            <p><xref ref-type="bibr" rid="prop1.REF.lemos.2006.479">Lemos et al [2006]</xref> described a novel initiation codon variant (c.2T&#x0003e;C), the first variant reported in exon 1, which appears to lead to a null allele that abolishes the translation of the PROP1 protein.</p>
          </list-item>
          <list-item>
            <p><xref ref-type="bibr" rid="prop1.REF.abr_o.2006.294">Abr&#x000e3;o et al [2006]</xref> reported complete deletion of <italic toggle="yes">PROP1</italic> in two siblings with GH deficiency associated with other pituitary hormone deficiencies (TSH, PRL, and gonadotropins). One of the siblings also had an evolving cortisol deficiency.</p>
          </list-item>
          <list-item>
            <p><xref ref-type="bibr" rid="prop1.REF.kelberman.2009.96">Kelberman et al [2009]</xref> reported compound heterozygosity for the c.373C&#x0003e;T and c.310delC variants associated with CPHD including ACTH deficiency. Two individuals harboring a complete <italic toggle="yes">PROP1</italic> deletion had normal cortisol secretion. <xref ref-type="bibr" rid="prop1.REF.kelberman.2009.96">Kelberman et al [2009]</xref> also reported an intronic c.343-11C&#x0003e;G variant associated with CPHD, which disrupts correct splicing resulting in the loss of exon 3 from the <italic toggle="yes">PROP1</italic> transcript.</p>
          </list-item>
          <list-item>
            <p><xref ref-type="bibr" rid="prop1.REF.zhang.2010.98">Zhang et al [2010]</xref> reported a deletion of a segment of about 53.2 kb encompassing <italic toggle="yes">PROP1</italic> and adjacent sequences in two pedigrees with CPHD.</p>
          </list-item>
        </list>
        <p>No autosomal dominant <italic toggle="yes">PROP1</italic> variants have been reported to date. (For more information see <related-object source-id="gene" document-id="prop1" object-id="prop1.molgen.TA">Table A</related-object>.)</p>
        <table-wrap id="prop1.T.selected_prop1_pathogenic_varian" position="anchor" orientation="portrait">
          <label>Table 3. </label>
          <caption>
            <p>Selected <italic toggle="yes">PROP1</italic> Pathogenic Variants</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change <break/>(Alias&#x000a0;<sup>1</sup>)</th>
                <th id="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Protein Amino Acid Change</th>
                <th id="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2T&#x0003e;C</td>
                <td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">(null allele)</td>
                <td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.109+1G&#x0003e;T<break/>(IVS1+1G&#x0003e;T)</td>
                <td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                <td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_3" rowspan="16" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_006261.4">NM_006261.4</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_006252.3">NP_006252.3</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.112_124del</td>
                <td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ser38ProfsTer123</td>
              </tr>
              <tr>
                <td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.150delA</td>
                <td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg53AspfsTer112</td>
              </tr>
              <tr>
                <td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.157delA</td>
                <td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg53AspfsTer112</td>
              </tr>
              <tr>
                <td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.211C&#x0003e;T</td>
                <td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg71Cys</td>
              </tr>
              <tr>
                <td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.212G&#x0003e;A</td>
                <td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg71His</td>
              </tr>
              <tr>
                <td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.217C&#x0003e;T</td>
                <td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg73Cys</td>
              </tr>
              <tr>
                <td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.218G&#x0003e;A</td>
                <td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg73His</td>
              </tr>
              <tr>
                <td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.247C&#x0003e;T</td>
                <td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gln83Ter</td>
              </tr>
              <tr>
                <td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.300_301delGA<break/>(GA296deletion)</td>
                <td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Leu102CysfsTer8</td>
              </tr>
              <tr>
                <td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.301_302delAG</td>
                <td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Leu102CysfsTer8</td>
              </tr>
              <tr>
                <td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.310delC</td>
                <td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg104GlyfsTer61</td>
              </tr>
              <tr>
                <td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.343-11C&#x0003e;G</td>
                <td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">--</td>
              </tr>
              <tr>
                <td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.373C&#x0003e;T</td>
                <td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg125Trp</td>
              </tr>
              <tr>
                <td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.467_468insT<break/>(467insT)</td>
                <td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Tyr157LeufsTer36</td>
              </tr>
              <tr>
                <td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.582G&#x0003e;A</td>
                <td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Trp194Ter</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the author. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn id="prop1.TF.3.1">
              <label>1.&#x000a0;</label>
              <p>Variant designation that does not conform to current naming conventions</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> The product of <italic toggle="yes">PROP1,</italic> homeobox protein prophet of PIT-1, has DNA-binding and transcriptional activation ability. Expression of homeobox protein prophet of PIT-1 is required for the ontogenesis of pituitary gonadotropes, somatotropes, lactotropes, and thyrotropes needed for the normal production of FSH, LH, GH, PrL, and TSH. Two conserved basic regions within the homeodomain are important for localization to the nucleus, DNA binding, and target gene activation. Missense variants in these two regions of <italic toggle="yes">PROP1</italic> result in CPHD, indicating the importance of these conserved sequences [<xref ref-type="bibr" rid="prop1.REF.guy.2004.263">Guy et al 2004</xref>].</p>
        <p><bold>Abnormal gene product.</bold> Products of mutant <italic toggle="yes">PROP1</italic> alleles have reduced or absent DNA-binding and transcriptional activation ability.</p>
      </sec>
      <sec id="prop1.References">
        <title>References</title>
        <sec id="prop1.Published_GuidelinesConsensus_Stat">
          <title>Published Guidelines/Consensus Statements</title>
          <ref-list id="prop1.Published_GuidelinesConsensus_Stat.reflist0">
            <ref id="prop1.REF1">
              <mixed-citation publication-type="webpage">Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://jcem.endojournals.org/content/85/11/3990.long">online</ext-link>. 2000. Accessed 9-28-15.</mixed-citation>
            </ref>
            <ref id="prop1.REF.ho.2007">
              <mixed-citation publication-type="webpage">Ho KK. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ghresearchsociety.org/files/2007_Consensus_AGHD.pdf">online</ext-link>. 2007. Accessed 9-28-15.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="prop1.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="prop1.Literature_Cited.reflist0">
            <ref id="prop1.REF.aarskog.1997.829">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Aarskog</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eiken</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bjerknes</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myking</surname>
                    <given-names>OL</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Pituitary dwarfism in the R271W Pit-1 gene mutation.</article-title>
                <source>Eur J Pediatr</source>
                <volume>156</volume>
                <fpage>829</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">9392392</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.abr_o.2006.294">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Abr&#x000e3;o</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leite</surname>
                    <given-names>MV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carvalho</surname>
                    <given-names>LR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Billerbeck</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishi</surname>
                    <given-names>MY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barbosa</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnhold</surname>
                    <given-names>IJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mendonca</surname>
                    <given-names>BB</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Combined pituitary hormone deficiency (CPHD) due to a complete PROP1 deletion.</article-title>
                <source>Clin Endocrinol (Oxf)</source>
                <volume>65</volume>
                <fpage>294</fpage>
                <lpage>300</lpage>
                <pub-id pub-id-type="pmid">16918947</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.ashkenazihoffnung.2010.721">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ashkenazi-Hoffnung</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lebenthal</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wyatt</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ragge</surname>
                    <given-names>NK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dateki</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukami</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogata</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phillip</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gat-Yablonski</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>A novel loss-of-function mutation in OTX2 in a patient with anophthalmia and isolated growth hormone deficiency.</article-title>
                <source>Hum Genet.</source>
                <volume>127</volume>
                <fpage>721</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">20396904</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.blethen.1997.418">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Blethen</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baptista</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuntze</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foley</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>LaFranchi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johanson</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Adult height in growth hormone (GH)-deficient children treated with biosynthetic GH. The Genentech Growth Study Group.</article-title>
                <source>J Clin Endocrinol Metab.</source>
                <volume>82</volume>
                <fpage>418</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">9024229</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.bottner.2004.5256">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bottner</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keller</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kratzsch</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stobbe</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weigel</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keller</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirsch</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kiess</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blum</surname>
                    <given-names>WF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfaffle</surname>
                    <given-names>RW</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>PROP1 mutations cause progressive deterioration of anterior pituitary function including adrenal insufficiency: a longitudinal analysis.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>89</volume>
                <fpage>5256</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">15472232</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.cohen.2003.4832">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>RN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>LE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Botero</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sagar</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jurkiewicz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Radovick</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Enhanced repression by HESX1 as a cause of hypopituitarism and septooptic dysplasia.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>88</volume>
                <fpage>4832</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">14557462</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.dateki.2010.4043">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dateki</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukami</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uematsu</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaji</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iso</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ono</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mizota</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yokoya</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Motomura</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kinoshita</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moriuchi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogata</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Mutation and gene copy number analyses of six pituitary transcription factor genes in 71 patients with combined pituitary hormone deficiency: identification of a single patient with LHX4 deletion.</article-title>
                <source>J Clin Endocrinol Metab.</source>
                <volume>95</volume>
                <fpage>4043</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">20534763</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.dattani.2003">
              <mixed-citation publication-type="other">Dattani MT (2003) DNA testing in patients with GH deficiency at the time of transition. Growth Horm IGF Res. 13 Suppl A:S122-9.</mixed-citation>
            </ref>
            <ref id="prop1.REF.dattani.1998.125">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dattani</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinez-Barbera</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>PQ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brickman</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gupta</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martensson</surname>
                    <given-names>IL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toresson</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fox</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wales</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hindmarsh</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krauss</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beddington</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>IC</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse.</article-title>
                <source>Nat Genet</source>
                <volume>19</volume>
                <fpage>125</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">9620767</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.de_graaff.2010.363">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>de Graaff</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Argente</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veenma</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drent</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitterlinden</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hokken-Koelega</surname>
                    <given-names>AC</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>PROP1, HESX1, POU1F1, LHX3 and LHX4 mutation and deletion screening and GH1 P89L and IVS3+1/+2 mutation screening in a Dutch nationwide cohort of patients with combined pituitary hormone deficiency.</article-title>
                <source>Horm Res Paediatr.</source>
                <volume>73</volume>
                <fpage>363</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">20389107</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.de_ridder.2007.925">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>de Ridder</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stijnen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hokken-Koelega</surname>
                    <given-names>AC</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Prediction of adult height in growth-hormone-treated children with growth hormone deficiency.</article-title>
                <source>J Clin Endocrinol Metab.</source>
                <volume>92</volume>
                <fpage>925</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">17179199</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.delado_y.1999.1645">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Delado&#x000eb;y</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fl&#x000fc;ck</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000fc;y&#x000fc;kgebiz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuhlmann</surname>
                    <given-names>BV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ebl&#x000e9;</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hindmarsh</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mullis</surname>
                    <given-names>PE</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>"Hot spot" in the PROP1 gene responsible for combined pituitary hormone deficiency.</article-title>
                <source>J Clin Endocrinol Metab.</source>
                <volume>84</volume>
                <fpage>1645</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">10323394</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.diaczok.2008.4351">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Diaczok</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romero</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zunich</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marshall</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Radovick</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>A novel dominant negative mutation of OTX2 associated with combined pituitary hormone deficiency.</article-title>
                <source>J Clin Endocrinol Metab.</source>
                <volume>93</volume>
                <fpage>4351</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">18728160</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.diaczok.2008.4351_1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Diaczok</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romero</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zunich</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marshall</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Radovick</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>A novel dominant negative mutation of OTX2 associated with combined pituitary hormone deficiency.</article-title>
                <source>J Clin Endocrinol Metab.</source>
                <volume>93</volume>
                <fpage>4351</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">18728160</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.fernandezrodriguez.2011.181">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fernandez-Rodriguez</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quinteiro</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barreiro</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marazuela</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pereiro</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pein&#x000f3;</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cabezas-Agr&#x000ed;cola</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dominguez</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casanueva</surname>
                    <given-names>FF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernabeu</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Pituitary stalk dysgenesis-induced hypopituitarism in adult patients: prevalence, evolution of hormone dysfunction and genetic analysis.</article-title>
                <source>Neuroendocrinology.</source>
                <volume>93</volume>
                <fpage>181</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">21304225</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.fl_ck.1998.3727">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fl&#x000fc;ck</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deladoey</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rutishauser</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ebl&#x000e9;</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marti</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mullis</surname>
                    <given-names>PE</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Phenotypic variability in familial combined pituitary hormone deficiency caused by a PROP1 gene mutation resulting in the substitution of Arg--&#x0003e;Cys at codon 120 (R120C).</article-title>
                <source>J Clin Endocrinol Metab.</source>
                <volume>83</volume>
                <fpage>3727</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">9768691</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.fofanova.1998.45">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fofanova</surname>
                    <given-names>OV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takamura</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kinoshita</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parks</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peterkova</surname>
                    <given-names>VA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evgrafov</surname>
                    <given-names>OV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goncharov</surname>
                    <given-names>NP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bulatov</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dedov</surname>
                    <given-names>II</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamashita</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>A mutational hot spot in the Prop-1 gene in Russian children with combined pituitary hormone deficiency.</article-title>
                <source>Pituitary.</source>
                <volume>1</volume>
                <fpage>45</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11081182</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.growth_hormone_research_society.2000.3990">
              <element-citation publication-type="journal">
                <person-group>
                  <collab>Growth Hormone Research Society</collab>
                </person-group>
                <article-title>Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society.</article-title>
                <source>J Clin Endocrinol Metab.</source>
                <year>2000</year>
                <month>Nov</month>
                <volume>85</volume>
                <issue>11</issue>
                <fpage>3990</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">11095419</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.guy.2004.263">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Guy</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hunter</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Showalter</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>TP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Charoonpatrapong</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sloop</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bidwell</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rhodes</surname>
                    <given-names>SJ</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Conserved amino acid sequences confer nuclear localization upon the Prophet of Pit-1 pituitary transcription factor protein.</article-title>
                <source>Gene</source>
                <volume>336</volume>
                <fpage>263</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">15246537</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.hal_sz.2006.255">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hal&#x000e1;sz</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toke</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pat&#x000f3;cs</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertalan</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>T&#x000f6;mb&#x000f6;l</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sallai</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hossz&#x000fa;</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muzsnai</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kov&#x000e1;cs</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>S&#x000f3;lyom</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fekete</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>R&#x000e1;cz</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>High prevalence of PROP1 gene mutations in Hungarian patients with childhood-onset combined anterior pituitary hormone deficiency.</article-title>
                <source>Endocrine.</source>
                <volume>30</volume>
                <fpage>255</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">17526936</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.ho.2007.695">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ho</surname>
                    <given-names>KK</given-names>
                  </name>
                  <etal/>
                </person-group>
                <article-title>Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia.</article-title>
                <source>Eur J Endocrinol.</source>
                <year>2007</year>
                <month>Dec</month>
                <volume>157</volume>
                <issue>6</issue>
                <fpage>695</fpage>
                <lpage>700</lpage>
                <pub-id pub-id-type="pmid">18057375</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.kelberman.2007.s3">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kelberman</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dattani</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Hypothalamic and pituitary development: novel insights into the aetiology.</article-title>
                <source>Eur J Endocrinol.</source>
                <volume>157</volume>
                <supplement>Suppl 1</supplement>
                <fpage>S3</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">17785694</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.kelberman.2009.96">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kelberman</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turton</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woods</surname>
                    <given-names>KS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mehta</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Khawari</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greening</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swift</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Otonkoski</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rhodes</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dattani</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Molecular analysis of novel PROP1 mutations associated with combined pituitary hormone deficiency (CPHD).</article-title>
                <source>Clin Endocrinol (Oxf)</source>
                <volume>70</volume>
                <fpage>96</fpage>
                <lpage>103</lpage>
                <pub-id pub-id-type="pmid">19128366</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.kim.2003.277">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shin</surname>
                    <given-names>YL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>GH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>TU</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoo</surname>
                    <given-names>HW</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Clinical characteristics and molecular analysis of PIT1, PROP1,LHX3, and HESX1 in combined pituitary hormone deficiency patients with abnormal pituitary MR imaging.</article-title>
                <source>Horm Res.</source>
                <volume>60</volume>
                <fpage>277</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">14646405</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.lebl.2005.389">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lebl</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vos&#x000e1;hlo</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfaeffle</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stobbe</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cern&#x000e1;</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Novotn&#x000e1;</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zapletalov&#x000e1;</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalvachov&#x000e1;</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000e1;na</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiss</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blum</surname>
                    <given-names>WF</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Auxological and endocrine phenotype in a population-based cohort of patients with PROP1 gene defects.</article-title>
                <source>Eur J Endocrinol.</source>
                <volume>153</volume>
                <fpage>389</fpage>
                <lpage>96</lpage>
                <pub-id pub-id-type="pmid">16131601</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.lemos.2006.479">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lemos</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gomes</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bastos</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leite</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Limbert</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carvalho</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bacelar</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monteiro</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fonseca</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Agapito</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castro</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Regateiro</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carvalheiro</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>PROP1 gene analysis in Portuguese patients with combined pituitary hormone deficiency.</article-title>
                <source>Clin Endocrinol (Oxf)</source>
                <volume>65</volume>
                <fpage>479</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">16984240</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.mclennan.2003.785">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McLennan</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeske</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cotterill</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cowley</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Penfold</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howard</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomsett</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choong</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Combined pituitary hormone deficiency in Australian children: clinical and genetic correlates.</article-title>
                <source>Clin Endocrinol (Oxf)</source>
                <volume>58</volume>
                <fpage>785</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">12780757</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.mcnay.2007.691">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McNay</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turton</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelberman</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woods</surname>
                    <given-names>KS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brauner</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papadimitriou</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keller</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keller</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haufs</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krude</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shalet</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dattani</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>HESX1 mutations are an uncommon cause of septooptic dysplasia and hypopituitarism.</article-title>
                <source>J Clin Endocrinol Metab.</source>
                <volume>92</volume>
                <fpage>691</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">17148560</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.mehta.2009">
              <mixed-citation publication-type="book">Mehta A, Gevers EF, Dattani MT. Congenital disorders of the hypothalamo-pituitary-somatotrope axis. In: Brook CDG, Clayton PE, Brown RS, eds. <italic toggle="yes">Brook&#x02019;s Clinical Pediatric Endocrinology</italic>. 6 ed. Boston, MA: Wiley-Blackwell; 2009:60-104.</mixed-citation>
            </ref>
            <ref id="prop1.REF.mendonca.1999.942">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mendonca</surname>
                    <given-names>BB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osorio</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Latronico</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Estefan</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lo</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnhold</surname>
                    <given-names>IJ</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Longitudinal hormonal and pituitary imaging changes in two females with combined pituitary hormone deficiency due to deletion of A301,G302 in the PROP1 gene.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>84</volume>
                <fpage>942</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">10084575</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.navardauskaite.2014.299">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Navardauskaite</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dusatkova</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Obermannova</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfaeffle</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blum</surname>
                    <given-names>WF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adukauskiene</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smetanina</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cinek</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verkauskiene</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lebl</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>High prevalence of PROP1 defects in Lithuania: phenotypic findings in an ethnically homogenous cohort of patients with multiple pituitary hormone deficiency.</article-title>
                <source>J Clin Endocrinol Metab.</source>
                <year>2014</year>
                <volume>99</volume>
                <fpage>299</fpage>
                <lpage>306</lpage>
                <pub-id pub-id-type="pmid">24178788</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.nose.2006.491">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nose</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tatsumi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakano</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amino</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Congenital combined pituitary hormone deficiency attributable to a novel PROP1 mutation (467insT).</article-title>
                <source>J Pediatr Endocrinol Metab.</source>
                <volume>19</volume>
                <fpage>491</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16759034</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.nystr_m.2011.208">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nystr&#x000f6;m</surname>
                    <given-names>HF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saveanu</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barbosa</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barlier</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Enjalbert</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glad</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palming</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johannsson</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brue</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Detection of genetic hypopituitarism in an adult population of idiopathic pituitary insufficiency patients with growth hormone deficiency.</article-title>
                <source>Pituitary.</source>
                <volume>14</volume>
                <fpage>208</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">21132537</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.osorio.2002.5076">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Osorio</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marui</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jorge</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Latronico</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lo</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leite</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Estefan</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mendonca</surname>
                    <given-names>BB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnhold</surname>
                    <given-names>IJ</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Pituitary magnetic resonance imaging and function in patients with growth hormone deficiency with and without mutations in GHRH-R, GH-1, or PROP-1 genes.</article-title>
                <source>J Clin Endocrinol Metab.</source>
                <volume>87</volume>
                <fpage>5076</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">12414875</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.paracchini.2003.142">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Paracchini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giordano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corrias</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellone</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matarazzo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bellone</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Momigliano-Richiardi</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bona</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Two new PROP1 gene mutations responsible for compound pituitary hormone deficiency.</article-title>
                <source>Clin Genet.</source>
                <volume>64</volume>
                <fpage>142</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12859410</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.pernasetti.2000.390">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pernasetti</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toledo</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vasilyev</surname>
                    <given-names>VV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashida</surname>
                    <given-names>CY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cogan</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Louren&#x000e7;o</surname>
                    <given-names>DM</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Mellon</surname>
                    <given-names>PL</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Impaired adrenocorticotropin-adrenal axis in combined pituitary hormone deficiency caused by a two-base pair deletion (301-302delAG) in the prophet of Pit-1 gene.</article-title>
                <source>J Clin Endocrinol Metab.</source>
                <volume>85</volume>
                <fpage>390</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">10634415</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.pf_ffle.2011.43">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pf&#x000e4;ffle</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klammt</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Pituitary transcription factors in the aetiology of combined pituitary hormone deficiency.</article-title>
                <source>Best Pract Res Clin Endocrinol Metab</source>
                <volume>25</volume>
                <fpage>43</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">21396574</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.phillips.1995">
              <mixed-citation publication-type="book">Phillips JA III. Inherited defects in growth hormone synthesis and action. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. <italic toggle="yes">The Metabolic Basis of Inherited Disease</italic>, 6 ed. New York, NY: McGraw-Hill; 1995:3023-44.</mixed-citation>
            </ref>
            <ref id="prop1.REF.pirinen.1994.144">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pirinen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Majurin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lenko</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koski</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>Craniofacial features in patients with deficient and excessive growth hormone.</article-title>
                <source>J Craniofac Genet Dev Biol.</source>
                <volume>14</volume>
                <fpage>144</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">7852543</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.rainbow.2005.163">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rainbow</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rees</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaikh</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaw</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cole</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barrett</surname>
                    <given-names>TG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirk</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Mutation analysis of POUF-1, PROP-1 and HESX-1 show low frequency of mutations in children with sporadic forms of combined pituitary hormone deficiency and septo-optic dysplasia.</article-title>
                <source>Clin Endocrinol (Oxf)</source>
                <volume>62</volume>
                <fpage>163</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15670191</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.ranke.1995.122">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ranke</surname>
                    <given-names>MB</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Growth hormone therapy in children: when to stop?</article-title>
                <source>Horm Res.</source>
                <volume>43</volume>
                <fpage>122</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">7750910</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.reynaud.2005.4880">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Reynaud</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barlier</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vallette-Kasic</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saveanu</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guillet</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simonin</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Enjalbert</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valensi</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brue</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>An uncommon phenotype with familial central hypogonadism caused by a novel PROP1 gene mutant truncated in the transactivation domain.</article-title>
                <source>J Clin Endocrinol Metab.</source>
                <volume>90</volume>
                <fpage>4880</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">15941866</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.reynaud.2004.5779">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Reynaud</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chadli-Chaieb</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vallette-Kasic</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barlier</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarles</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pellegrini-Bouiller</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Enjalbert</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chaieb</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brue</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>A familial form of congenital hypopituitarism due to a PROP1 mutation in a large kindred: phenotypic and in vitro functional studies.</article-title>
                <source>J Clin Endocrinol Metab.</source>
                <volume>89</volume>
                <fpage>5779</fpage>
                <lpage>86</lpage>
                <pub-id pub-id-type="pmid">15531542</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.reynaud.2006.3329">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Reynaud</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gueydan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saveanu</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vallette-Kasic</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Enjalbert</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brue</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barlier</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Genetic screening of combined pituitary hormone deficiency: experience in 195 patients.</article-title>
                <source>J Clin Endocrinol Metab.</source>
                <year>2006</year>
                <volume>91</volume>
                <fpage>3329</fpage>
                <lpage>36</lpage>
                <pub-id pub-id-type="pmid">16735499</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.riepe.2001.4353">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Riepe</surname>
                    <given-names>FG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Partsch</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blankenstein</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monig</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfaffle</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sippell</surname>
                    <given-names>WG</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Longitudinal imaging reveals pituitary enlargement preceding hypoplasia in two brothers with combined pituitary hormone deficiency attributable to PROP1 mutation.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>86</volume>
                <fpage>4353</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">11549674</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.rimoin.1997">
              <mixed-citation publication-type="book">Rimoin DL, Phillips JA III. Genetic disorders of the pituitary gland. In: Rimoin DL, Connor JM, Pyeritz RE, eds. <italic toggle="yes">Principles and Practice of Medical Genetics</italic>. 3 ed. New York, NY: Churchill Livingstone; 1997:1331-64</mixed-citation>
            </ref>
            <ref id="prop1.REF.roessler.2003.13424">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Roessler</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Du</surname>
                    <given-names>YZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mullor</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casas</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allen</surname>
                    <given-names>WP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gillessen-Kaesbach</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roeder</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ming</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruiz</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Altaba</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muenke</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Loss-of-function mutations in the human GLI2 gene are associated with pituitary anomalies and holoprosencephaly-like features.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <volume>100</volume>
                <fpage>13424</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">14581620</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.ros_n.1995.93">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ros&#x000e9;n</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johannsson</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johansson</surname>
                    <given-names>JO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bengtsson</surname>
                    <given-names>BA</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Consequences of growth hormone deficiency in adults and the benefits and risks of recombinant human growth hormone treatment. A review paper.</article-title>
                <source>Horm Res.</source>
                <volume>43</volume>
                <fpage>93</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">7721271</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.rosenfeld.1996">
              <mixed-citation publication-type="book">Rosenfeld RG. Disorders of growth hormone and insulin-like growth factor secretion and action. In: Sperling MA, ed. <italic toggle="yes">Pediatric Endocrinology</italic>. 1 ed. Philadelphia, PA: WB Saunders. 1996:117-70.</mixed-citation>
            </ref>
            <ref id="prop1.REF.solomon.2004.669">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Solomon</surname>
                    <given-names>NM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgan</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belsky</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hol</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karnes</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hopwood</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myers</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warne</surname>
                    <given-names>GL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forrest</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>PQ</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Array comparative genomic hybridisation analysis of boys with X linked hypopituitarism identifies a 3.9 Mb duplicated critical region at Xq27 containing SOX3.</article-title>
                <source>J Med Genet.</source>
                <volume>41</volume>
                <fpage>669</fpage>
                <lpage>78</lpage>
                <pub-id pub-id-type="pmid">15342697</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.tatsumi.2004.635">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tatsumi</surname>
                    <given-names>KI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kikuchi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsumura</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amino</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>A novel PROP1 gene mutation (157delA) in Japanese siblings with combined anterior pituitary hormone deficiency.</article-title>
                <source>Clin Endocrinol (Oxf)</source>
                <volume>61</volume>
                <fpage>635</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">15521968</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.turton.2005.10">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Turton</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mehta</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raza</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woods</surname>
                    <given-names>KS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tiulpakov</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cassar</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chong</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>PQ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eunice</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ammini</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouloux</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Starzyk</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hindmarsh</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dattani</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Mutations within the transcription factor PROP1 are rare in a cohort of patients with sporadic combined pituitary hormone deficiency (CPHD).</article-title>
                <source>Clin Endocrinol (Oxf)</source>
                <volume>63</volume>
                <fpage>10</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15963055</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.vallettekasic.2001.4529">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vallette-Kasic</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barlier</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teinturier</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diaz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manavela</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berthez&#x000e8;ne</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouchard</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chaussain</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brauner</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pellegrini-Bouiller</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaquet</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Enjalbert</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brue</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotroph deficiency.</article-title>
                <source>J Clin Endocrinol Metab.</source>
                <volume>86</volume>
                <fpage>4529</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">11549703</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.vieira.2007.1097">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vieira</surname>
                    <given-names>TC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boldarine</surname>
                    <given-names>VT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abucham</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Molecular analysis of PROP1, PIT1, HESX1, LHX3, and LHX4 shows high frequency of PROP1 mutations in patients with familial forms of combined pituitary hormone deficiency.</article-title>
                <source>Arq Bras Endocrinol Metabol.</source>
                <volume>51</volume>
                <fpage>1097</fpage>
                <lpage>103</lpage>
                <pub-id pub-id-type="pmid">18157385</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.vivenza.2011.705">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vivenza</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Godi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faienza</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellone</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moia</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rapa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petri</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bellone</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riccomagno</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cavallo</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giordano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bona</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>A novel HESX1 splice mutation causes isolated GH deficiency by interfering with mRNA processing.</article-title>
                <source>Eur J Endocrinol.</source>
                <volume>164</volume>
                <fpage>705</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">21325470</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.voutetakis.2004a.2200">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Voutetakis</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Argyropoulou</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sertedaki</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Livadas</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xekouki</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maniati-Christidi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bossis</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thalassinos</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patronas</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dacou-Voutetakis</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2004a</year>
                <article-title>Pituitary magnetic resonance imaging in 15 patients with Prop1 gene mutations: pituitary enlargement may originate from the intermediate lobe.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>89</volume>
                <fpage>2200</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15126542</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.voutetakis.2004b.257">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Voutetakis</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maniati-Christidi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kanaka-Gantenbein</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dracopoulou</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Argyropoulou</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Livadas</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dacou-Voutetakis</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sertedaki</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2004b</year>
                <article-title>Prolonged jaundice and hypothyroidism as the presenting symptoms in a neonate with a novel Prop1 gene mutation (Q83X).</article-title>
                <source>Eur J Endocrinol</source>
                <volume>150</volume>
                <fpage>257</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">15012608</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.voutetakis.2004c.454">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Voutetakis</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sertedaki</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Livadas</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maniati-Christidi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mademtzis</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bossis</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dacou-Voutetakis</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Messinis</surname>
                    <given-names>IE</given-names>
                  </name>
                </person-group>
                <year>2004c</year>
                <article-title>Ovulation induction and successful pregnancy outcome in two patients with Prop1 gene mutations.</article-title>
                <source>Fertil Steril</source>
                <volume>82</volume>
                <fpage>454</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">15302300</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.woods.2005.833">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Woods</surname>
                    <given-names>KS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cundall</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turton</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rizotti</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mehta</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palmer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chong</surname>
                    <given-names>WK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Zyoud</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El-Ali</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Otonkoski</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinez-Barbera</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>PQ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>IC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lovell-Badge</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woodward</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dattani</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Over- and underdosage of SOX3 is associated with infundibular hypoplasia and hypopituitarism.</article-title>
                <source>Am J Hum Genet.</source>
                <volume>76</volume>
                <fpage>833</fpage>
                <lpage>49</lpage>
                <pub-id pub-id-type="pmid">15800844</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.wu.1998.147">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cogan</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pf&#x000e4;ffle</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dasen</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frisch</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Connell</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flynn</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mullis</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parks</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phillips</surname>
                    <given-names>JA</given-names>
                    <suffix>3rd</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Rosenfeld</surname>
                    <given-names>MG</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Mutations in PROP1 cause familial combined pituitary hormone deficiency.</article-title>
                <source>Nat Genet.</source>
                <volume>18</volume>
                <fpage>147</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">9462743</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.zhang.2010.98">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Han</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shi</surname>
                    <given-names>D.</given-names>
                  </name>
                </person-group>
                <article-title>A large deletion of PROP1 gene in patients with combined pituitary hormone deficiency from two unrelated Chinese pedigrees.</article-title>
                <source>Horm Res Paediatr.</source>
                <year>2010</year>
                <volume>74</volume>
                <fpage>98</fpage>
                <lpage>105</lpage>
                <pub-id pub-id-type="pmid">20395664</pub-id>
              </element-citation>
            </ref>
            <ref id="prop1.REF.zimmermann.2007.587">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zimmermann</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schenk</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grigorescu Sido</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfaffle</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lazea</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimmermann</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heinrich</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bettendorf</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>MRI findings and genotype analysis in patients with childhood onset growth hormone deficiency--correlation with severity of hypopituitarism.</article-title>
                <source>J Pediatr Endocrinol Metab.</source>
                <volume>20</volume>
                <fpage>587</fpage>
                <lpage>96</lpage>
                <pub-id pub-id-type="pmid">17642419</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="prop1.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="prop1.Suggested_Reading.reflist0">
            <ref id="prop1.REF.tajima.2010.405">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tajima</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yorifuji</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishizu</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujieda</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>A novel mutation (V101A) of the LHX4 gene in a Japanese patient with combined pituitary hormone deficiency.</article-title>
                <source>Exp Clin Endocrinol Diabetes.</source>
                <volume>118</volume>
                <fpage>405</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">19856252</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="prop1.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="prop1.Author_History">
          <title>Author History</title>
          <p>Laura CG de Graaff, MD, PhD (2011-present)Lawrence C Layman, MD; Medical College of Georgia (1999-2011)John A Phillips III, MD; Vanderbilt University Medical Center (1999-2011)Cindy Vnencak-Jones, PhD; Vanderbilt University Medical Center (1999-2011)</p>
        </sec>
        <sec id="prop1.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>7 August 2014 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>6 October 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>21 November 2005 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>16 June 2003 (ca) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>7 December 2000 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>18 October 1999 (jp) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
